Valuation: NIOX Group Plc

Market Cap 274M 369M 320M 302M 513M 35.34B 517M 3.6B 1.39B 17.93B 1.39B 1.35B 57B P/E 2026 *
29.6x
P/E 2027 * 24.9x
Enterprise Value 246M 331M 287M 271M 461M 31.77B 465M 3.24B 1.25B 16.12B 1.24B 1.22B 51.24B EV / Sales 2026 *
4.88x
EV / Sales 2027 * 4.32x
Free-Float
79.07%
Yield 2026 *
2.62%
Yield 2027 * 2.97%
1 day+0.59%
1 week-2.12%
Current month-3.85%
1 month-3.00%
3 months+15.92%
6 months+5.45%
Current year-1.53%
1 week 65
Extreme 65
68.8
1 month 65
Extreme 65
69.8
Current year 53.84
Extreme 53.84
72
1 year 53.84
Extreme 53.84
76
3 years 53.4
Extreme 53.4
80
5 years 29
Extreme 29
80
10 years 12.5
Extreme 12.5
115.61
Manager TitleAgeSince
Chief Executive Officer - 16/01/2025
Director of Finance/CFO - 14/05/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 58 08/02/2018
Director/Board Member - 02/09/2019
Chairman 73 05/12/2019
Date Insider Type Main position Quantity % Market Cap. Importance
29/5/26 Buy

Chief Financial Officer

34,127 0.0081%
29/5/26 Sell

Chief Financial Officer

-33,916 0.0081%
28/5/26 Sell

Chief Financial Officer

-34,219 0.0081%
Change 5-day change 1-year change 3-year change Capi.($)
+0.59%-2.12%-6.86%-3.85% 369M
+2.02%-0.96%+50.69%+92.40% 1,015B
+0.28%-3.24%+49.57%+62.65% 642B
+1.81%+2.07%+19.89%+70.38% 463B
-0.69%+2.85%+38.44%+37.94% 353B
+0.05%+2.22%+17.02%+23.87% 265B
-0.20%+2.11%+6.24%+10.84% 254B
+1.10%-12.75%+38.03%+45.44% 206B
-0.07%-3.72%-20.83%-57.82% 191B
+1.87%-3.04%+27.81%+89.26% 182B
Average +0.58%-3.46%+22.00%+37.11% 357.06B
Weighted average by Cap. +0.57%-2.21%+33.89%+56.99%

Financials

2026 *2027 *
Net sales 50.36M 67.89M 58.83M 55.51M 94.48M 6.51B 95.16M 663M 255M 3.3B 255M 249M 10.49B 54.24M 73.12M 63.36M 59.79M 102M 7.01B 102M 714M 275M 3.56B 275M 269M 11.3B
Net income 10.99M 14.81M 12.83M 12.11M 20.61M 1.42B 20.76M 145M 55.74M 720M 55.63M 54.4M 2.29B 12.76M 17.21M 14.91M 14.07M 23.94M 1.65B 24.12M 168M 64.75M 837M 64.62M 63.2M 2.66B
Net Debt -27.67M -37.31M -32.33M -30.51M -51.92M -3.58B -52.29M -364M -140M -1.81B -140M -137M -5.77B -38.99M -52.56M -45.54M -42.98M -73.14M -5.04B -73.67M -513M -198M -2.56B -197M -193M -8.12B
Logo NIOX Group Plc
NIOX Group plc is a United Kingdom-based diagnostics and management company. The Company is engaged in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNO), a precise biomarker for asthma. The Company's NIOX VERO is also the device of choice by clinical research organizations for respiratory studies. The device is used by healthcare professionals to improve asthma care, which assists diagnosis, determining responsiveness to inhaled corticosteroids, tailoring inhaled steroid use, monitoring treatment compliance, and reducing the likelihood of exacerbations in at-risk patients compared to traditional monitoring. The Company provides products and services via its direct sales organization and extensive distributor network in over 50 countries.
Employees
97
Date Price Change Volume
15/09/26 GBX 65.38 +0.59% 15,457
14/09/26 GBX 65.00 -1.52% 521,755
11/09/26 GBX 66.00 +1.54% 203,656
10/09/26 GBX 65.00 0.00% 917,281
09/09/26 GBX 65.00 -2.69% 396,725
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
0.6500GBP
Average target price
0.8150GBP
Spread / Average Target
+25.38%

Annual profits - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!